Seema Bhat
Clinical trials sponsored by Seema Bhat, explained in plain language.
-
Heart-Safe CLL treatment? study switches patients to acalabrutinib
Disease control Recruiting nowThis study tests whether acalabrutinib, a targeted cancer drug, can control chronic lymphocytic leukemia (CLL) without the heart side effects often caused by a similar drug, ibrutinib. About 61 adults with CLL who had heart problems on ibrutinib will switch to acalabrutinib. Rese…
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Yearly shots may shield leukemia patients from dangerous infections
Prevention Recruiting nowThis study tests whether giving yearly pneumococcal vaccines to people with chronic lymphocytic leukemia (CLL) offers better protection than the current standard of revaccination every 5 years. About 80 untreated CLL patients will receive either the yearly schedule or the standar…
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Prevention
Last updated May 08, 2026 12:02 UTC